These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36733376)

  • 41. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation.
    Padilla S; Polotskaya K; Fernández M; Gonzalo-Jiménez N; de la Rica A; García JA; García-Abellán J; Mascarell P; Gutiérrez F; Masiá M
    J Antimicrob Chemother; 2022 Jul; 77(8):2257-2264. PubMed ID: 35534369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients.
    Bistrovic P; Besic D; Cikara T; Antolkovic L; Bakovic J; Radic M; Stojic J; Osmani B; Hrabar M; Martinkovic J; Delic-Brkljacic D; Lucijanic M
    Rev Cardiovasc Med; 2023 Aug; 24(8):238. PubMed ID: 39076723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of Clinical Outcome and Healthcare Modalities of COVID-19 Patients Treated With Remdesivir at a Tertiary Care Teaching Hospital.
    Acharya TA; Joshi KJ; Patel DD; Shah SN; Mehta DS
    Cureus; 2022 Jan; 14(1):e21535. PubMed ID: 35106259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany.
    Marx K; Gončarova K; Fedders D; Kalbitz S; Kellner N; Fedders M; Lübbert C
    Infection; 2023 Feb; 51(1):97-108. PubMed ID: 35553032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early initiation of remdesivir and its effect on oxygen desaturation: A clinical review study among high-risk COVID-19 patients in Myanmar.
    Aye TT; Myat K; Tun HP; Thiha P; Han TM; Win YY; Han AMM
    J Family Med Prim Care; 2022 Aug; 11(8):4644-4649. PubMed ID: 36352909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database.
    Jung SY; Kim MS; Li H; Lee KH; Koyanagi A; Solmi M; Kronbichler A; Dragioti E; Tizaoui K; Cargnin S; Terrazzino S; Hong SH; Abou Ghayda R; Kim NK; Chung SK; Jacob L; Salem JE; Yon DK; Lee SW; Kostev K; Kim AY; Jung JW; Choi JY; Shin JS; Park SJ; Choi SW; Ban K; Moon SH; Go YY; Shin JI; Smith L
    Clin Transl Sci; 2022 Feb; 15(2):501-513. PubMed ID: 34719115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review.
    Nabati M; Parsaee H
    Cardiovasc Toxicol; 2022 Mar; 22(3):268-272. PubMed ID: 34643857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy.
    Colaneri M; Amarasinghe N; Rezzonico L; Pieri TC; Segalini E; Sambo M; Roda S; Meloni F; Gregorini M; Rampino T; Pelenghi S; Ricciardi A; Bruno R
    Int J Infect Dis; 2022 Aug; 121():157-160. PubMed ID: 35533831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
    Elsawah HK; Elsokary MA; Abdallah MS; ElShafie AH
    Rev Med Virol; 2021 Jul; 31(4):e2187. PubMed ID: 33128490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA;
    N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support.
    Alibrahim RS; Elmekaty EZ; Elmekaty MZI; Edbais M; Alkhatib M; Daghfal J; Almaslamani MA; Omrani AS
    Qatar Med J; 2022; 2022(3):25. PubMed ID: 36072086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
    Patel RH; Pella PM; Haider N; Blanco R
    Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel.
    Goldberg E; Ben Zvi H; Sheena L; Sofer S; Krause I; Sklan EH; Shlomai A
    Clin Microbiol Infect; 2021 Jun; 27(6):917.e1-917.e4. PubMed ID: 33705849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of bradycardia during SARS CoV-2 infection in a 14-year-old child.
    Kilicaslan O; Isancli DK; Ulutas OY; Ergin SO; Karbuz A
    Infect Dis (Lond); 2021 Jul; 53(7):555-558. PubMed ID: 33760677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia.
    Nasrallah S; Nguyen AQ; Hitchings L; Wang JQ; Hamade S; Maxwell GL; Khoury A; Gomez LM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5970-5977. PubMed ID: 33771091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study.
    Sourander B; Andersson LM; Brink M; Yilmaz A; Sundell N; Marklund E; Nilsson S; Lindh M; Robertson J; Gisslén M
    Infect Dis (Lond); 2022 Oct; 54(10):703-712. PubMed ID: 35708280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.
    Tamura S; Kaki T; Niwa M; Yamano Y; Kawai S; Yamashita Y; Tanaka H; Saito Y; Kajimoto Y; Koizumi Y; Yamaue H; Nakao N; Nojiri T; Hironishi M
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056426
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience.
    Russo A; Binetti E; Borrazzo C; Cacciola EG; Battistini L; Ceccarelli G; Mastroianni CM; d'Ettorre G
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.